Doctor profile · Federal record

Dr. Christopher Haberman, M.D.

Hematology (Internal Medicine) Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Medical Oncology Physician · Panama City, FL

  • NPI 1750590931
  • Accepts Medicare
  • MIPS 86.3 / 100 · 2023
  • 24 yrs in practice
  • Licensed in 2 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2100 State Ave
Panama City, FL 324054587
(850) 763-0036
fax (850) 763-0259

Credentials & registration

NPPES · NUCC
NPI registered
May 2007 — 19 yrs on file
Profile last updated
February 25, 2025
Year of graduation
2002 — 24 yrs since
Specialty taxonomy
207RH0000X — NUCC code
State licenses (2)
Florida #ME143843 · Georgia #059653
Medicaid (4)
SC #304744 · GA #844093264B · GA #844093264A · GA #844093264C

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1750590931. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
162,977
Distinct HCPCS
10
Medicare allowed
$2,543,792
HCPCS Description Services Patients Avg allowed
J1439 Injection, ferric carboxymaltose, 1 mg 60,750 43 $1
J9299 Injection, nivolumab, 1 mg 15,400 11 $30
J1453 Injection, fosaprepitant, 1 mg 14,550 27 $0
J0897 Injection, denosumab, 1 mg 12,540 35 $23
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 11,520 11 $47
J9271 Injection, pembrolizumab, 1 mg 10,400 14 $55
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units 6,540 22 $7
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 5,700 48 $0
J9267 Injection, paclitaxel, 1 mg 4,470 12 $0
Q5118 Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg 3,180 11 $28

In context: peer comparison

Among 3 peers in this city , average services per provider: 4,514. This provider delivers 36× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,438
Transactions
114
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 20 $384.99
Regeneron Healthcare Solutions, Inc. 13 $368.81
Janssen Biotech, Inc. 13 $194.49
Celgene Corporation 9 $186.83
AstraZeneca Pharmaceuticals LP 9 $183.28
E.R. Squibb & Sons, L.L.C. 9 $174.56
Daiichi Sankyo Inc. 7 $146.70
JAZZ PHARMACEUTICALS INC. 3 $97.81
BeiGene USA, Inc. 5 $89.82
Pharmacosmos Therapeutics Inc. 5 $87.61
Genentech USA, Inc. 5 $87.55
ABBVIE INC. 4 $87.47
PFIZER INC. 5 $84.99
Eisai Inc. 4 $84.19
Ipsen Biopharmaceuticals, Inc 3 $79.03

By nature of payment

Food and Beverage
$3,404
Education
$34

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
576
Patients
172
Total drug cost
$1,712,461
Drug Type Claims Patients Total cost
Anastrozole Generic 82 20 $1,918
Ondansetron Odt (Ondansetron) Brand 70 50 $1,644
Revlimid (Lenalidomide) Brand 62 0 $1,059,829
Prochlorperazine Maleate Generic 53 43 $787
Hydroxyurea Generic 43 13 $1,516
Letrozole Generic 42 11 $1,970
Fentanyl Generic 35 0 $7,000
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 34 11 $738
Prednisone Generic 30 12 $325
Lenalidomide Generic 29 0 $410,892

Frequently asked questions

Auto-generated from federal data
What is Dr. Christopher Haberman's medical specialty?
Dr. Christopher Haberman practices Hematology (Internal Medicine) Physician in Panama City, FL.
Where does Dr. Christopher Haberman practice?
Dr. Christopher Haberman practices at 2100 State Ave, Panama City, FL 324054587. Office phone: 8507630036.
What is Dr. Christopher Haberman's NPI?
Dr. Christopher Haberman's National Provider Identifier (NPI) is 1750590931, issued by NPPES.
Does Dr. Christopher Haberman accept Medicare assignment?
Yes. Dr. Christopher Haberman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Christopher Haberman commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, nivolumab, 1 mg (HCPCS J9299); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.